Leavitt outlines government’s ‘convenor’ role in healthcare IT April 29, 2005 By Christopher Delporte
Avanir, Novartis Enter $210M Agreement On Inflammation April 29, 2005 Avanir Pharmaceuticals Inc. partnered its first preclinical program, doing so with Novartis AG to develop small-molecule drugs that target macrophage migration inhibitory factor.(BioWorld Today)Read More
RSS